Detalhe da pesquisa
1.
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.
Breast Cancer Res Treat
; 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797792
2.
p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers.
Biochem Biophys Res Commun
; 529(3): 582-589, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32736677
3.
Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase.
Prostaglandins Other Lipid Mediat
; 116-117: 57-63, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25677506
4.
Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.
Int J Mol Sci
; 15(10): 17886-900, 2014 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25290095
5.
Single-dose trastuzumab monotherapy achieved pathological complete response (pCR) in a patient with HER2-positive breast cancer: a case report.
Surg Case Rep
; 9(1): 112, 2023 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341815
6.
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04).
Breast Cancer
; 30(2): 293-301, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609911
7.
Breast reconstruction using a tissue expander after enucleation of a giant fibroadenoma: A case report.
Int J Surg Case Rep
; 90: 106723, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991047
8.
MIEAP, a p53-downstream gene, is associated with suppression of breast cancer cell proliferation and better survival.
Am J Cancer Res
; 11(12): 6060-6073, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35018242